About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, January 5th, 2016

The QualityStocks
Daily Stock List


Carolco Pictures, Inc. (CRCO)

StockMister, Fortune Stock Alerts, PennyPickAlerts, Penny Stocks Profile, 1-2-3 Stock Alerts, Penny Stock Circle, Juicy Penny Stocks and ThePUMPTracker reported on Carolco Pictures, Inc. (CRCO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Carolco Pictures, Inc. is a diversified entertainment company that lists on the OTC Markets’ OTCQB. The Company engages in the financing, production and leasing of motion picture properties. Carolco creates feature films and television entertainment content. Carolco Pictures has U.S. offices in New York, New York; Beverly Hills, California; Boca Raton, Florida; and Nashville, Tennessee.

The Company formerly went by the name Brick Top Productions, Inc. In November of 2014, media and entertainment company Brick Top Productions acquired the rights to the name Carolco and effective December 31, 2014, changed its corporate name to Carolco Pictures, Inc. In association with the name change, Carolco joined up with Mr. Mario Kassar, one of Carolco’s original founders and the producer and executive producer of international blockbuster films for more than three decades, to deliver future films.

Mr. Kassar has released 36 motion pictures that have been nominated for 16 Academy Awards. His films as producer and executive producer have grossed over $3 billion (today’s value) in worldwide theatrical box office.

Founded in 2009, Carolco is a name synonymous with worldwide blockbusters including Terminator 2: Judgment Day; Total Recall; and the first three movies of the Rambo series (First Blood, Rambo: First Blood Part II, and Rambo III) and multi-billion-dollar box office revenues.
Carolco Pictures, through its subsidiary, S&G Holdings, Inc., specializes in the development and presentation of television programming. This includes TV series, specials, pilots, live events, and also award shows.

In May 2015, Carolco Pictures announced that it entered into an agreement with Mr. Kassar to produce certain feature length motion pictures. In addition to producer and sales services, Mr. Kassar will remain Carolco Pictures' Chairman of the Board.

In June 2015, Carolco Pictures announced that its majority owned subsidiary, High Five Entertainment, celebrated its fifth successful production of the CMT Music Awards Red Carpet Show on June 10, 2015. Founded in Los Angeles, California in 1983, High Five Entertainment is a globally recognized, Emmy Award-winning entertainment production company headquartered in Nashville, Tennessee. High Five specializes in the development and presentation of quality television programming. This includes music series, specials, unscripted television, live events, as well as award shows.

Carolco Pictures, Inc. (CRCO), closed Tuesday's trading session at $0.0053, up 307.69%, on 12,217,875 volume with 147 trades. The average volume for the last 60 days is 1,864,298 and the stock's 52-week low/high is $0.001/$1.50.

PharmaCyte Biotech, Inc. (PMCB)

SmallCapNetwork, Cannabis Financial Network News, Goldman Small Cap Research, OTCJournal, SmallCapVoice, and BUYINS.NET reported earlier on PharmaCyte Biotech, Inc. (PMCB), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company that focuses on developing targeted treatments for cancer and diabetes applying its signature live cell encapsulation technology, Cell-in-a-Box®. This innovative and patented technology is being used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. PharmaCyte Biotech has its corporate head office in Silver Spring, Maryland.

In addition, the Company is working towards improving the quality of life of patients with advanced pancreatic cancer and on developing treatments for other types of solid cancerous tumors. It is ready to head into Phase 2b clinical trials in advanced inoperable pancreatic cancer in Australia.

PharmaCyte Biotech’s treatment for pancreatic cancer involves low doses of the recognized anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or "cancer-killing" form. These capsules are placed as close to the cancerous tumor as possible. This is to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer.

PharmaCyte Biotech is also developing treatments for cancer founded upon chemical constituents of the Cannabis plant, called cannabinoids. It is examining ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects generally associated with cancer treatments.

The live-cell encapsulation technology that it employs is a way to enclose living cells in protective “cocoons” around the size of the head of a pin. PharmaCyte encapsulates living cells, not drugs.  Each capsule can enclose around 10,000 cells. This number can vary depending upon the size of the cells encapsulated.

PharmaCyte Biotech made headlines in the diabetes industry after a study was published that stated its Melligen cell line could produce insulin in diabetic mice. The Company has the exclusive worldwide rights to use the Melligen cells to treat diabetes.

Yesterday, PharmaCyte Biotech announced its 2016 milestones as the Company advances its new treatment for pancreatic cancer into the clinic in the U.S., with study sites in Europe and Australia. PharmaCyte Biotech’s CEO, Mr. Kenneth L. Waggoner, stated, “We are excited to see 2016 arrive as this is the year that we will get into the clinic with our pancreatic cancer treatment.”

The Company’s clinical trial in pancreatic cancer will get underway with Translational Drug Development (TD2) coordinating the trial internationally and conducting it in the U.S.  Clinical Network Services (CNS) will conduct the trial in Europe and Australia in alliance with TD2.

PharmaCyte Biotech, Inc. (PMCB), closed Tuesday's trading session at $0.0775, up 37.17%, on 4,579,571 volume with 432 trades. The average volume for the last 60 days is 2,189,652 and the stock's 52-week low/high is $0.0385/$0.2615.

That Marketing Solution, Inc. (TSTS)

Epic Stock Picks, Wolf of Penny Stocks, OTCStars.com, Hot Stock Profits, StockMarketIntel, and Value Penny Stocks reported earlier on That Marketing Solution, Inc. (TSTS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Salt Lake City, Utah-based, That Marketing Solution, Inc. develops and markets health related products. The Company owns and operates technology around the Micellization Manufacturing Process. This proprietary Micellization Process converts oil based nutrients into water soluble products for better absorption by cells. The Company’s commitment is to developing select brands that it owns in the anti-aging and health wellness sectors. That Marketing Solution lists on the OTC Bulletin Board.

The Company owns the rights to Low T Vitamin Formula. This product is for men over 30 with decreased levels of testosterone. That Marketing Solution has acquired Aqua V Micellization Technology. The acquisition terms give it the exclusive rights to the existing Aqua V Intellectual Property (IP) and potential patent applications that will apply to this category of technology.  This is a proprietary nutritional innovation.

Aqua V Micellization Technology makes it possible to adapt fat-soluble compounds into water-soluble compounds outside of the body, effectively increasing bioavailability. The Aqua V Technology exponentially increases the nutritional benefits of bio-nutrients to the body. This is while decreasing the amount of raw ingredients needed to manufacture the nutritional formula.

Many of the most important bio-nutrients that people supplement in their diets, are fat-soluble. The body must micellize the supplement through breaking it down. This leaves only a part of the bio-nutrient available for uptake. Through utilizing the proprietary Aqua V Technology to adapt the nutrient outside of the body, the uptake is almost immediate. Furthermore, the formulation has almost no bio-waste in the process. This allows formulators to use less active ingredient in their formulas to get the maximum benefit. It controls the delivery of the exact amount of nutritional value to the body.

That Marketing Solution has received Kosher certification for three products. These three products are all manufactured using the Company’s proprietary Aqua V Micellization technology.

In November 2015, the Company announced that it successfully scaled the production of micellized CBD Oil to commercial batch size quantities. CBD is a phytocannabinoid. CBD is found in industrial hemp and marijuana.

Mr. Matt Smith, That Marketing Solution President, said, "We're very excited that we have successfully scaled micellized CBD Oil production. This now opens the door to many monetization options that we plan to examine."

That Marketing Solution, Inc. (TSTS), closed Tuesday's trading session at $0.0016, up 23.08%, on 6,516,610 volume with 44 trades. The average volume for the last 60 days is 19,442,762 and the stock's 52-week low/high is $0.0011/$0.586.

Epoxy, Inc. (EPXY)

TopPennyStockMovers reported earlier on Epoxy, Inc. (EPXY), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Epoxy, Inc. is the developer of the Epoxy App, which is an application or "app" for iPhone iOS and Android operating systems. Epoxy is an inventive smart phone application. The design of it is to conveniently connect business owners and consumers to reduce marketing frustrations. Epoxy is a fully integrated mobile application business. The commitment of Epoxy designers is to provide a superior and user-friendly product for business owners to reward loyal customers. The OTCQB-listed Company is based in Las Vegas, Nevada.

The Epoxy mobile app gives loyal customers the ease of keeping track of rewards and punch cards all in one place. This is while also giving opportunities to review and share businesses with friends.  Epoxy provides businesses the ability to reward, share offers, and deliver information about special events with its customers, and offer card-less gift cards directly through smart phones.

The Company has been targeting professional business services to add to its developing portfolio of clients. This includes Optometry, Health and Wellness, as well as Technology firms.

In April 2015, Epoxy announced that it successfully completed its Phase one expansion into Germany. It has started working on Phase two. Phase one consists of rendering the best types of markets and deploying the Epoxy App in English. Phase Two consists of translating the Application to German and offering the German marketplace incentives for signing up.

Epoxy has created an entirely different admin panel. The new admin panel design is cleaner and more intuitive. It provides business owners total control over the implementation of the Epoxy App. This control includes access to high-end analytics that report metrics. Business owners will also be able to easily update page content and send messages to the entire network, or single out and reward individual customers.

Recently, Epoxy announced a partnership with premier development company Phontronix. This partnership is to assist with the next stage of development and expansion of Epoxy's mobile app. Moreover, last month, Epoxy announced that Epoxy Mobile App is offering a new white label version to businesses. It permits current and potential clients to have a customized app for a fraction of the price. The purpose is to reduce costs without sacrificing any of the original Epoxy app features people desire.

Epoxy, Inc. (EPXY), closed Tuesday's trading session at $0.006, up 20.00%, on 1,045,135 volume with 33 trades. The average volume for the last 60 days is 466,562 and the stock's 52-week low/high is $0.0032/$0.18.

Bravatek Solutions, Inc. (BVTK)

Today we are reporting on Bravatek Solutions, Inc. (BVTK), here at the QualityStocks Daily Newsletter.

Listed in the OTCQB, Bravatek Solutions, Inc. provides security, defense, and information security solutions. These solutions assist corporate entities, governments and individuals in protecting their organizations and/or critical infrastructures against error, and physical and cyber-attack. The orientation of Bravatek's business operations are around the marketing and distribution of proprietary and allied security, defense and information security software, hardware and services. The Company previously went by the name Ecrypt Technologies, Inc. It changed its name to Bravatek Solutions, Inc. in September of 2015.

Bravatek Solutions’ chief business operations center on expanding its strategic marketing program of allied products and services of which Bravatek has designation as the exclusive, or non-exclusive, marketing and distribution agent within the United States and internationally. Furthermore, Bravatek has developed and plans to continue selling an enterprise-level secure email software appliance called Ecrypt One.

Ecrypt One is an email server with integrated security technology. The design of it is to protect email and attachments in transit and at rest. Ecrypt One incorporates numerous security technologies and techniques, including encryption, role based access controls, server rules that enforce security, and multi-factor authentication. The design of Ecrypt One was to help organizations and governments meet and maintain compliance with information security regulations such as HIPAA. Bravatek Solutions filed a patent application for multiple processes in Ecrypt One, with a request for non-publication, on April 22, 2014.

The Company strategically acquired some of the assets of Viking Telecom Services, LLC, on June 2, 2015. Viking Telecom Services is a Minnesota limited liability company from Dependable Critical Infrastructure, Inc. f/k/a DTREDS Consolidated Inc., a Delaware corporation. Bravatek continues to provide Viking telecommunication services under the "Viking," "Viking Telecom," and "Viking Tower" brands. Services provided include cellular tower mapping and audits, ground audits, civil equipment installation, cellular site decommissioning, 3G/4G installations, project/construction management, battery installation and maintenance, plowing/snow removal, shelter and compound preventative maintenance, site cleanup, and other related services.

Over the next twelve months, Bravatek Solutions intends to continue distribution on Ecrypt One Software packages; continue fulfilling Viking Telecom services backlog; continue distribution of allied products and services; continue developing its strategic marketing alliance program; and continue development and testing of additional Ecrypt One features and capabilities.

Bravatek Solutions specializes in five key markets. These are Healthcare; Government and Military; Law Enforcement; Legal Services, and Financial Services.

Bravatek Solutions, Inc. (BVTK), closed Tuesday's trading session at $0.0006, down 14.29%, on 198,155,558 volume with 327 trades. The average volume for the last 60 days is 2,219,855 and the stock's 52-week low/high is $0.0003/$1.68.


The QualityStocks
Company Corner


Oakridge Global Energy Solutions, Inc. (OGES)

The QualityStocks Daily Newsletter would like to spotlight Oakridge Global Energy Solutions, Inc. (OGES). Today, On the Move Systems, Inc. closed trading at $0.85, up 3.66%, on 26,905 volume with 52 trades. The stock’s average daily volume over the past 60 days is 22,823, and its 52-week low/high is $0.1505/$2.40.

Oakridge Global Energy Solutions, Inc. was excited to announce today that it has sold its entire interest, 11,000,000 shares, of European battery manufacturing company Leclanché (LECN), with financial close dated December 30, 2015. While details of this transaction are under non-disclosure with the buyer, Golden Partner Management SPC of Luxemburg, the purpose of the sale is to make available the necessary capital to fund Oakridge's previously announced expansion strategy.

Oakridge Global Energy Solutions, Inc. (OGES) specializes in the development of cutting-edge technology to transform and synchronize freight supply chain operations for a broad range of industries. The company is exploring new online tools to reduce costs and increase convenience in the tourism and travel industry, as well as new opportunities in trucking. OMVS works with a premier group of international providers to offer its services in two key divisions: Trucking Logistics and Inter-modal Freight.

Logistics are critical to the success of any operation. OMVS's Trucking Logistics division operates as one of the most competitive, full-service transportation logistics providers in the United States. Utilizing the company's ISTx Platform, this division helps customers strategize how to get from one point to another, as well as solves some of the toughest logistics challenges on the road today. OMVS's Trucking Logistics technology provides customers increased visibility, minimal-cost route effectiveness, and delivery assurance.

OMVS's Intermodal Freight division offers seamless cargo continuation, tracking, shipping and receiving of goods anywhere in the world. The company's customer service teams and drivers communicate through the ISTx Platform allowing for flexibility, control and monitoring of each freight shipment. OMVS continues to research and explore the most effective and resourceful tools in order to effectively serve customers with unique shipping requirements in the billion dollar trucking industry.

In his more than 20 years of experience, OMVS president and CEO Robert Wilson has cultivated vast expertise as an executive and financial consultant for companies in aviation, energy, oil and gas, IT and healthcare. In addition to his work valuing and assessing small-to-middle market companies, Wilson has also served as both an officer and director of such client companies. Wilson applies his expertise in the transportation business and investment banking to spearhead OMVS's new initiative to create a new kind of online transportation platform to an international market. Disclaimer

Oakridge Global Energy Solutions, Inc. Company Blog

Oakridge Global Energy Solutions, Inc. News:

Oakridge Sells Interest in Leclanche S.A., Releasing Funding for Corporate Growth

Oakridge Global Energy Solutions to Be Highlighted on FOX Business Network’s “New To The Street”

Oakridge Global Energy Solutions Announces Q3 Results

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $3.35, up 8.06%, on 6,388 volume with 29 trades. The stock’s average daily volume over the past 60 days is 19,111, and its 52-week low/high is $1.25/$11.625.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Signed a Clinical Service Agreement With the Florey Institute of Neuroscience and Mental Health

International Stem Cell Corporation Receives Authorization to Initiate Phase I/IIa Clinical Trial of ISC-hpNSC for the Treatment of Parkinson's Disease

International Stem Cell Corporation Announces Launch Plans for New Nano-Compound Products

OurPet's Company (OPCO)

The QualityStocks Daily Newsletter would like to spotlight OurPet's Company (OPCO). Today, OurPet's Company closed trading at $0.88, up 3.53%, on 1,340 volume with 4 trades. The stock’s average daily volume over the past 60 days is 6,616, and its 52-week low/high is $0.45/$1.00.

OurPet's Company (OPCO) develops, produces and markets various pet accessory and consumable products designed to awaken pets' natural instincts, be it in feeding, playing or waste management. Sold globally through pet specialty retailers, food, drug and mass chains, e-commerce and international channels, the company's products are marketed under a the OurPets®, Pet Zone® and PetTastic® brands with well-known sub-brands such as Play-N-Squeak™, Cosmic Catnip™, Durapet, SmartScoop and Flappy. In total, OurPet's has an intellectual property portfolio featuring more than 160 individual patents, giving the company sustainable access to the pet products industry for the foreseeable future.

In recent years, the U.S. pet products and services market has experienced strong growth, with total sales accounting for approximately $73 billion in 2014, according to a report by Packaged Facts. In 2015, this strong performance is expected to continue, building on the recent rise in related ecommerce purchases, as well as an uptick in dog and cat ownership throughout the country. In order to capitalize on this market performance, OurPet's maintains an ongoing new product development program to continually keep an evolutionary and revolutionary new product pipeline feeding its offerings. In July 2015, OurPet's introduced many new products at the national Super Zoo trade show in Las Vegas such as the Catty Whack®, Designer Diner™/Barking Bistro™ and the Zoom Plume™.

The company's capitalization strategy is guided by a management team of experienced industry professionals dedicated to further strengthening its product portfolio through aggressive development of innovative products. Management has a proven track-record of leveraging deep knowledge in the innovation, technology, distribution and pet markets to successfully push through adverse market conditions to achieve increases in revenue, margins and net income.

OurPet's, through its innovative and extensive line of popular pet products, is in a favorable strategic position to continue building upon its recent market growth. For prospective shareholders, this positioning makes the company an intriguing investment opportunity in the months to come. Look for OurPet's to capitalize on steady market performance moving forward, providing an opportunity for the company to realize strong investor returns in the future. Disclaimer

OurPet's Company Company Blog

OurPet's Company News:

Dean Tsengas Named Chief Operations Officer of OurPet's Company

OurPet's Company (OPCO) Named 'Company of the Month' in November Issue of The Bowser Report

OurPet's Company Reports Q3 2015 Results, Including Record Net Revenue of Nearly $6.0 Million -- Net Income Up 428% to $410,450

Moxian, Inc. (MOXC)

The QualityStocks Daily Newsletter would like to spotlight Moxian, Inc. (MOXC). Today, Moxian, Inc. closed trading at $5.05, up 1.00%, on 1,004 volume with 4 trades. The stock’s average daily volume over the past 60 days is 863, and its 52-week low/high is $4.50/$6.50.

Moxian, Inc. (MOXC) engages in the business of providing social marketing and promotion platforms designed to help merchants accelerate and advertise their business growth through social media. These products and services enable merchants to run targeted advertising campaigns and promotions, and aim to enhance the interaction between users and merchant clients by using consumer behavior data compiled from the Moxian database of user activities. The company has two primary core products: Moxian+ User App and Moxian+ Business App.

Developed in Shenzhen, China, Moxian integrates social media, entertainment and business intelligence. The Multi-Channel Social Commerce Platform, which includes a variety of tools such as Moxian's proprietary Social Customer Relationship Management (SCRM) system, generates knowledgeable data for merchants. This way, consumers and businesses are able to connect and interact with one another to achieve the concept of "online lifestyle, offline fun."

Moxian+ User App serves as an App driven for consumer users to use the platform, consisting of our proprietary virtual currency (MO-Coin and MO-Points), social networking, redemption centre and game centre. Users can earn MO-Coins by playing games, and then use those coins to redeem prizes sponsored by Moxian and client merchants. This model not only drives registered consumers to Moxian and merchant, but also provides merchants the opportunity to advertise, run marketing campaigns, and learn about their customers through the Platform.

Moxian+ Business App is an independent App with built in Social Customer Relationship Management tool built for merchants. Merchants are able to set up a store on the Moxian platform through this business App, push promotions via a variety of methods offered on the platform and look at generated report customized to their own shop.

Moxian's management team has more than 100 years of combined experience in a variety of pertinent endeavors, including management of private and public enterprise, multi-national organizations, quality, engineering and procurement, finance, marketing, communication and more. Together, Moxian's management team is effecting the company's aim to create and lead a personalized social network platform that best fits users and businesses. Disclaimer

Moxian, Inc. Company Blog

Moxian, Inc. News:

Moxian, Inc. Establishes Beijing Subsidiary, Defines Expansion Plans

MissionIR Exclusive Audio Interview With Moxian, Inc. (MOXC) Creative & Marketing VP Edmund Ooi

Moxian, Inc. (MOXC) Announces Engagement of DreamTeamNetwork Corporate Communications Service Suite

Legacy Ventures International, Inc. (LGYV)

The QualityStocks Daily Newsletter would like to spotlight Legacy Ventures International, Inc. (LGYV). Today, Legacy Ventures International, Inc. closed trading at $1.17, off by 4.88%, on 115,169 volume with 179 trades. The stock’s average daily volume over the past 60 days is 33,091, and its 52-week low/high is $0.01/$2.50.

Legacy Ventures International, Inc. (LGYV) is an investment company seeking out high-potential businesses with big ideas that can be scaled in order to promote hyper growth. The company fuels innovation and passion by providing the capital, oversight and connections that young businesses need to reach their full potential.

Legacy is led by a highly-qualified executive team with decades of relevant industry experience. Evan Clifford, the company's chief executive officer, has spent more than 15 years building and maintaining relationships with some of North America's most influential executives. Over the past decade, he has served as a lead advisor to a collection of companies and individuals striving for personal and professional success. Likewise, Rehan Saeed, Legacy's chief financial officer, has over a decade of experience in the banking industry during which he built and managed a real estate portfolio valued at $110 million.

The company's current brand portfolio is headlined by newly-acquired RM Fresh Brands, a servicer of food and beverage retailers and distributors around the globe. RM Fresh Brands takes a unique approach to brand partnerships by maintaining a clear focus on sustainable, category-changing consumables. This strategy has helped it build an extensive portfolio of highly-desirable brands – including Boxed Water, Aloe Gloe, Uncle Si's Iced Tea and Chef 5-Minute Meals.

Following the successful acquisition of RM Fresh Brands, Legacy is in a strong strategic position to move forward with its efforts to promote sustainable growth. The company will lean on the considerable experience of its management team as it looks to build on its recent progress while promoting maximized shareholder value. Disclaimer

Legacy Ventures International, Inc. Company Blog

Legacy Ventures International, Inc. News:

Legacy Ventures Welcomes G. Scott Paterson to the Advisory Committee

Legacy Ventures International Due Diligence Report: Being Green is in; Boxed Water a Step Closer to Reducing the Carbon Footprint

Legacy Ventures Subsidiary RM Fresh Brands Completes Agreement to Supply Products to Sysco for Distribution


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters







Daily Trade Alert

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251